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Schwann cells produce myelin sheaths and thereby
permit rapid saltatory conductance in the vertebrate
peripheral nervous system. Their stepwise differenti-
ation from neural crest cells is driven by a defined
set of transcription factors. How this is linked to
chromatin changes is not well understood. Here we
show that the glial transcription factor Sox10 func-
tions in Schwann cells by recruiting Brg1-contain-
ing chromatin-remodeling complexes via Baf60a
to regulatory regions of Oct6 and Krox20 genes.
It thereby stimulates expression of these transcrip-
tional regulators that then cooperate with Sox10
to convert immature into myelinating Schwann
cells. The functional interaction between Sox10
and Brg1 is evident from gain- and loss-of-function
studies, similar neuropathies in the corresponding
mouse mutants, and an aggravated neuropathy in
compound mutants. Our results demonstrate that
the transcription factor-mediated recruitment of
the chromatin-remodeling machinery to specific
genomic loci is an essential driving force for
Schwann cell differentiation and myelination.
INTRODUCTION
The transcription factor Sox10 is required in the Schwann cell
lineage for specification from pluripotent neural crest cells and
for the stepwise progression of these glia to a myelinating state
(Britsch et al., 2001; Finzsch et al., 2010; Jessen and Mirsky,
2005; Wegner and Stolt, 2005). Even maintenance of mature
Schwann cells and their myelin sheath in the adult vertebrate
still requires Sox10 (Bremer et al., 2011). In accord with its role
as a key regulator of Schwann cell development and homeo-
stasis, functional impairment by heterozygous mutation causes
peripheral neuropathies in humans (Inoue et al., 2004; Pingault
et al., 1998). Evidence has been gathered that Sox10 induces
other stage-specific transcriptional regulators with which itDevethen interacts in a cascade-like, feedforward mechanism to
direct Schwann cell development (Finzsch et al., 2008; Ghislain
and Charnay, 2006; Jagalur et al., 2011; Jones et al., 2007; Re-
iprich et al., 2010; Svaren and Meijer, 2008). These are Oct6
and Krox20 as essential factors for the transition from immature
into promyelinating, and from promyelinating into myelinating
Schwann cells, respectively (Jaegle et al., 1996; Topilko et al.,
1994). The mechanism of their induction by Sox10 is, however,
only partly understood (Ghislain and Charnay, 2006; Jagalur
et al., 2011; Reiprich et al., 2010).
Recent experiments suggested that Schwann cell differentia-
tionmay involve epigenetic changes and alterations in chromatin
structure. Although there is evidence that histone deacetylases
1 and 2 are required for peripheral myelination (Chen et al.,
2011; Jacob et al., 2011), it is not clear to what extent their
function involves histone modification rather than deacetylation
of specific transcription factors and how this may translate into
altered chromatin structure.
Alterations of chromatin structure furthermore require the
activity of chromatin-remodeling complexes. Schwann cell-
specific deletion of Chd4 as the core subunit of the NuRD
chromatin-remodeling complex has recently been shown to
affect peripheral myelination. However, effects were late, mostly
transient, and mild (Hung et al., 2012) and therefore argue
against a central role of the NuRD complex in Schwann cell
development and developmental myelination.
BAF complexes on the other hand have come into focus
as chromatin-remodeling complexes with important functions
during development (Ho and Crabtree, 2010; Ho et al., 2009;
Lessard et al., 2007; Lickert et al., 2004; Takeuchi and Bru-
neau, 2009). They consist of multiple general and facultative
subunits, and their activity requires Brg1 or the related Brm
as ATPase (Hargreaves and Crabtree, 2011; Ho and Crabtree,
2010). Until now there are only a few studies on the role of
BAF complexes during nervous system development, and
these have been restricted to very early phases. Inactivation
of Brg1 pointed to functions in neural precursors, and defects
in the specification of neural crest cells and glia in the central
nervous system have been proposed (Eroglu et al., 2006;
Matsumoto et al., 2006). Here we address the role of BAF
complexes in Schwann cell development by deleting the core
subunit Brg1.lopmental Cell 23, 193–201, July 17, 2012 ª2012 Elsevier Inc. 193
Figure 1. Physical Interactions between
Sox10 and BAF Complex Components
(A) Sox10 structure and Sox10 fragments used
in yeast two-hybrid assays (Gal4) and GST pull-
downs (Tag) are schematically outlined on the left,
whereas the right shows results from yeast two-
hybrid assays with Baf60a as prey (right) pre-
sented as mean b-galactosidase units ± SEM. K2,
conserved region 2; TA, transactivation domain.
(B) Baf60a structure and fragments used as GST
fusions are outlined schematically.
(C and D) Pull-down assays with Baf60a fragments
immobilized as GST fusions on Sepharose beads
and either full-length Sox10 from 293 cell extracts
(C) or bacterially expressed purified Sox10 frag-
ments (D).
(E and F) GST pull-down assays with immobilized
Sox10 fragments to precipitate full-length Baf60
isoforms (E) or Brg1 (F) from extracts of trans-
fected 293 cells.
(G) Coimmunoprecipitation (IP) of endogenous
Baf60a with anti-Sox10 antibodies (aSox10, upper
part) and of endogenous Sox10 with anti-Baf60a
antibodies (aBaf60a, lower part) from S16 cell
extracts (Input). The upper panels show western
blot (WB) detection of the protein against which the
specific antibody was directed, whereas the lower
panels show the coimmunprecipitated protein.
Preimmune serum (PI) and mouse IgG (IG) served
as control.
See also Figure S1.
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Sox10 Physically Interacts with Components of the BAF
Chromatin-Remodeling Complex
We performed a yeast two-hybrid screen and identified Baf60a,
one of the facultative subunits of the BAF chromatin-remodeling
complex, as a Sox10 interactor, leading to the hypothesis that
Sox10 function may depend on the activity of such complexes.
Using different Sox10 deletion mutants, the interacting region
was narrowed down to the amino-terminal half of Sox10 (Fig-
ure 1A). This contains the dimerization domain (Dim; Figure 1A)
and the adjacent high-mobility group (HMG; Figure 1A) domain
that is responsible for DNA binding and mediates contacts with
many transcription factors (Guth and Wegner, 2008; Wissmu¨ller
et al., 2006). However, neither Dim nor HMG domain sufficed for
efficient Baf60a interaction in yeast (Figure 1A).
Interaction between both proteins was confirmed in vitro in
glutathione S-transferase (GST) pull-down assays. Using bacte-194 Developmental Cell 23, 193–201, July 17, 2012 ª2012 Elsevier Inc.rially produced, affinity-purified GST
fusions with different Baf60a parts (Fig-
ure 1B) and Sox10 from transfected
293 cell extracts, contacts with Sox10
were exclusively detected for the amino-
terminal third of Baf60a (Figure 1C). This
part also interacts with nuclear hormone
receptors (Hsiao et al., 2003). When
63His-tagged, bacterially produced and
purified Sox10 regions were used in-
stead of holoprotein from transfectedcell extracts, interactions were again limited to the amino-
terminal third of Baf60a and on the side of Sox10 to the region
encompassing Dim and HMG domain (Figure 1D). Other func-
tionally relevant regions of Sox10 such as K2 and the transacti-
vation domain did not interact. The same results were obtained
in the reverse setup, i.e., with Sox10 domains fused to GST (Fig-
ure 1E; data not shown). Intriguingly, Sox10 only interacted with
Baf60a, and not with its two close relatives Baf60b and Baf60c,
which can replace Baf60a in the complex (Figure 1E). The Sox10
region encompassing Dim and HMG domain also interacted
with Brg1 from transfected 293 cell extracts (Figure 1F). Because
of the presence of Baf60a in the reaction interaction of the BAF
complex ATPase Brg1 with Sox10 may be indirect andmediated
by Baf60a. In coimmunoprecipitation experiments antibodies
directed against Sox10 efficiently precipitated Baf60a from
S16 Schwann cell extracts just as antibodies directed against
Baf60a precipitated Sox10 (Figure 1G). This confirms interaction
between endogenous proteins in Schwann cells.
Figure 2. Perinatal Phenotypic Alterations in Brg1-Deficient Spinal Nerves
(A–C) Coimmunohistochemistry with antibodies directed against Sox10 (green) and Sox2 (red, A), Oct6 (red, B) or Krox20 (red, C) on wild-type (WT) and Brg1D/D
spinal nerve sections at E18.5. Nuclei were counterstained with DAPI (blue).
(D–J) Quantification of DAPI-stained nuclei (D), Sox10-labeled cells (E), Ki67-positive proliferating cells (F), TUNEL-positive apoptotic cells (G), Sox2-labeled cells
(H), Oct6-positive cells (I), and Krox20-expressing cells (J) per 2,500 mm2 in E18.5 wild-type (WT) and Brg1D/D spinal nerves. At least 20 sections from three
individuals per genotype were used. Data are presented as mean ± SEM. Differences were statistically significant between wild-type and Brg1D/Dmutant where
indicated (***p% 0.001, Student’s t test).
(K) In situ hybridization of E18.5 wild-type (WT) and Brg1D/D spinal nerves with probes specific for Mbp and Mpz.
Scale bars, 15 mm (A–C) and 100 mm (K).
See also Figure S2.
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the Absence of Brg1
Using immunohistochemistry on spinal nerves, both Brg1 and
Baf60a were found coexpressed with Sox10 in Schwann cells
at all embryonic and postnatal stages analyzed (see Figure S1A
available online). During this time Schwann cells progress from
the Schwann cell precursor stage via the immature, Sox2-
positive stage and the promyelinating, Oct6-positive stage into
the myelinating, Krox20-positive stage (Jessen and Mirsky,
2005). Colocalization with Sox2, Oct6, and Krox20 confirmed
that Baf60a and Brg1 are present during all stages (Figure S1B).
Brg1 was specifically deleted in vivo in Schwann cells using
a mouse model with floxed Brg1 alleles and the Schwann cell-
specific Dhh::Cre transgene (Jaegle et al., 2003; Sumi-Ichinose
et al., 1997). By embryonic day (E) 18.5, Brg1 was completely
deleted fromSchwann cells alongperipheral nerves (Figure S1A).
This did not affect Baf60a expression (Figure S1A) nor did it
dramatically influence Schwann cell numbers along peripheral
nerves as measured by the number of DAPI-positive nucleiDeve(Figures 2A–2D). Schwann cells furthermore remained Sox10
positive (Figures 2A–2C and 2E). Rates of proliferation and
apoptosis were likewise unaltered (Figures 2F and 2G). However,
a dramatic change in the expression profile of stage-specific
Schwann cell markers occurred. Compared to the wild-type,
there were still many Sox2-positive immature Schwann cells
(Figures 2A and 2H) but too few Oct6-positive promyelinating
Schwann cells (Figures 2B and 2I) and even fewer Krox20-posi-
tive myelinating Schwann cells (Figures 2C and 2J). This is
a strong indication of a Schwann cell differentiation defect. In
agreement, expression of the myelin genes Mbp and Mpz was
substantially downregulated in Brg1D/D mice (Figure 2K).
Mice with Brg1-Deficient Schwann Cells Develop
a Severe Peripheral Neuropathy
During the first 2 weeks after birth, Brg1D/D mice were indistin-
guishable from wild-type littermates and gained weight normally
(Figure S2A). However, from the third week onward, Brg1D/D
mice were much less active, exhibited an unstable, wobblinglopmental Cell 23, 193–201, July 17, 2012 ª2012 Elsevier Inc. 195
Figure 3. Ultrastructural Alterations in the Brg1-Deficient Sciatic Nerve, Genetic Interaction of Sox10 and Brg1, and Brg1 Binding to Sox10
Target Genes In Vivo
(A and B) Overview of sciatic nerve ultrastructure in wild-type (A) andBrg1D/D (B) mice at postnatal day 24.Whereas the wild-type nerve containsmanymyelinated
large caliber axons and small caliber axons in Remak bundles (white arrow in A), theBrg1D/D nerve containsmainly large, unsorted axon bundles (white arrow in B)
and few sorted axons with promyelinating Schwann cells (black arrow in B).
(C and D) Comparison of Schwann cell basal lamina (arrows) in wild-type (C) and Brg1D/D (D) sciatic nerves.
(E and F) Magnifications from Brg1D/D sciatic nerves showing sorted axons in contact with a promyelinating Schwann cell (black arrow in E), naked (white arrow in
E), and thinly myelinated (black arrow in F).
(G) Survival of wild-type (WT), Brg1D/D, and Brg1D/DSox10+/D mice during the first 32 days after birth.
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(Figures S2A and S2B). The phenotype worsened over time
(Figure S2B). By day 22 all Brg1D/D mice exhibited signs of hin-
dlimb paralysis (score 2 or higher in Figure S2B). By day 30 hin-
dlimbs were completely paralyzed in Brg1D/D mice (score 3 in
Figure S2B), and some started to show additional forelimb paral-
ysis (score 4 in Figure S2B). Peripheral nerves such as the sciatic
nerve were translucent in Brg1D/Dmice, whereas they were opa-
que in wild-type littermates (Figure S2C). This lack of myelin was
corroborated by the dramatic reduction ofMpz andMbp expres-
sion levels and paraphenylenediamine (PPD)-stained material
in the nerve (Figure S2D). At day 24, rates of proliferation and
apoptosis were both increased inBrg1D/D sciatic nerves (Figures
S2E and S2F). Considering that fewer DAPI-stained nuclei were
present in Brg1D/D nerves than in wild-type nerves (Figure S2G),
cell death seemed to prevail. The overall reduction in cell number
was mirrored by a reduction of Sox10-positive Schwann cells
(Figure S2H). The vast majority of Schwann cells in Brg1D/D
nerves expressed Sox2, whereas Oct6 and Krox20 expressing
Schwann cells were strongly reduced in number (Figures S2I–
S2N). This is completely opposite to the wild-type sciatic nerve
where the majority of Schwann cells express Krox20 and Oct6,
but not Sox2. In Brg1D/D nerves Schwann cells were thus
reduced in number, and most were arrested in the immature
state. In contrast, there was no alteration in the number of von
Willebrand factor-positive endothelial cells (Figure S2O), des-
min-positive pericytes (Figure S2P), and CD3-positive lympho-
cytes (Figure S2Q). The number of Iba1-positive macrophages
was only slightly increased (Figure S2R).
Mice with Brg1-Deficient Schwann Cells Exhibit
a Radial-Sorting Defect Similar to Mice with Sox10-
Deficient Schwann Cells
A similar arrest of Schwann cells in the immature state had also
been observed in mice in which Sox10 had been conditionally
deleted using the Dhh::Cre transgene (Finzsch et al., 2010). To
closely compare phenotypes, we performed ultrastructural anal-
yses of Brg1D/D sciatic nerves. In contrast to the wild-type, most
axons had not undergone radial sorting at day 24 (Figures 3A
and 3B). Large diameter axons were furthermore not myelinated
and instead still present in large bundles intermingled with small
diameter axons (Figure 3B). These axon bundles were encircled(H) ChIP with Brg1 antibodies and control IgGswere performed on chromatin prep
first transfected with expression plasmids for Brg1-specific (white bars) or Sox
by FACS using cotransfected GFP. qPCRs were carried out on immunoprecipitat
loci, and theGapdh gene. These were used to determine the relative enrichment o
were performed at least six times for wild-type S16 cells and three times for shR
(I) ChIP with Brg1 antibodies and control IgGs on chromatin prepared from sciatic
mice at postnatal day 6. qPCRs on immunoprecipitated chromatin with primer pa
enrichments in the Brg1 over the IgG immunoprecipitate were determined. Experi
from theOct6 and Krox20 gene loci included theOct6 SCE, theOct6 promoter (PO
the Krox20 transcribed region (TK), as well as several additional upstream (18,
position is schematically presented at the top of (H) and (I). Note the slightly diffe
(J) Quantification of Oct6 and Krox20 expression levels by quantitative RT-PCR
Sox10D/D (gray bars) mice at postnatal day 16. After normalization to Rpl8, wild-
pressed relative to it (n = 3).
Data shown in (H)–(J) are presented asmean ± SEM. Error bars represent the differ
D), and 250 nm (E and F).
See also Figure S3.
Deveas a whole by Schwann cell membranes and additionally sur-
rounded by collagen and elastic fibers. Schwann cell basal
laminae in Brg1D/D mice were considerably thinner than in the
wild-type and often incomplete (Figures 3C and 3D). This has
been similarly observed in Sox10D/D mice (Finzsch et al., 2010).
In difference to Sox10D/D mice, a minority of large caliber axons
in Brg1D/D sciatic nerves had succeeded in establishing a 1:1
relationship with Schwann cells (Figures 3B, 3E, and 3F). Most
of these sorted axons were in contact with a promyelinating
Schwann cell (Figure 3E). Only very rarely did we find axons
with thin myelin sheaths (Figure 3F). Despite these alterations,
axons did not exhibit substantial structural abnormalities. This
was even the case for completely naked axons that were detect-
able in sciatic nerves at day 24 following loss of their associated
Schwann cell through apoptosis (Figure 3E).
Sox10 Interacts Genetically and Functionally with the
BAF Chromatin-Remodeling Complex in Activating the
Schwann Cell Differentiation Program
The Schwann cell phenotype in Brg1D/D mice was dramatically
enhanced by additional heterozygous loss of one Sox10 allele,
which on its own had no effect on Schwann cell development
(Finzsch et al., 2010). Whereas the vast majority of Brg1D/D
mice survived the first month, most Brg1D/D Sox10+/D mice
died during the third week at which time they already showed
tetraparesis (Figure 3G). This genetic interaction and the pheno-
typic similarities between Brg1D/D and Sox10D/D mice could be
consequences of an effector-target-gene relationship. Consid-
ering that Sox10 continued to be expressed in the absence of
Brg1 and that loss of Sox10 did not impact Brg1 or Baf60a
expression in Schwann cells (Figure S1A), an effector-target-
gene relationship was discounted. Functional interaction as a
result of physical interaction was a more likely cause.
Chromatin immunoprecipitations (ChIPs) with Brg1 antibodies
from S16 Schwann cell chromatin led to specific enrichment of
the Schwann cell enhancer (SCE) approximately 10 kb down-
stream of the Oct6 transcriptional start and the myelinating
Schwann cell enhancer (MSE) far downstream of the Krox20
transcriptional start (Figure 3H, black bars). The same regulatory
regions have previously been shown to be responsible for Oct6
and Krox20 expression in differentiating Schwann cells through
direct Sox10 binding (Ghislain and Charnay, 2006; Jagalurared fromwild-type S16 Schwann cells (black bars), or Schwann cells that were
10-specific shRNAs (gray bars) and then separated from untransfected cells
ed chromatin with primer pairs for several regions of the Oct6 and Krox20 gene
f the studied regions in the Brg1 over the IgG immunoprecipitate. Experiments
NA-treated S16 cells with each PCR in triplicate.
nerves of wild-type (black bars), Brg1D/D (white bars), and Sox10D/D (gray bars)
irs for several regions of theOct6 and Krox20 gene loci followed, before relative
ments were performed at least three times with each PCR in triplicate. Regions
), theOct6 transcribed region (TO), theKrox20MSE, theKrox20 promoter (PK),
13, 2, 1) and downstream (+7, +16, +32, +36, +42) regions. Their relative
rent location of MSE and SCE in rat (H) and mouse (I) genomes.
on sciatic nerve RNA from wild-type (black bars), Brg1D/D (white bars), and
type levels were set to 100%, and expression levels in the mutants were ex-
ences between biological replicates. Scale bars, 1 mm (A and B), 100 nm (C and
lopmental Cell 23, 193–201, July 17, 2012 ª2012 Elsevier Inc. 197
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regions in the upstream or downstream flanks of the Oct6 and
Krox20 genes exhibited a comparable enrichment, and neither
promoters nor transcribed sequenceswere preferentially precip-
itated from chromatin by Brg1 antibodies. Transcribed Gapdh
sequences also showed no enrichment. When ChIP experiments
were performed on S16 cells after transfection with an expres-
sion plasmid for a Brg1-specific shRNA and fluorescence-acti-
vated cell sorting (FACS) to greater than 90% purity using
cotransfected GFP, SCE and MSE enrichments were no longer
detected (Figure 3H, white bars). Intriguingly, enrichment of
the Oct6 and Krox20 gene enhancers was also dramatically
reduced when S16 cells were transfected with Sox10-specific
shRNAs before FACS and ChIP (Figure 3H, gray bars). The effi-
cacy of both shRNAs was validated in western blots (Figures
S3A and S3B).
Anti-Brg1 antibodies preferentially precipitated Oct6 SCE and
Krox20MSE also from chromatin prepared from sciatic nerves of
wild-type mice (Figure 3I, black bars), but not from chromatin
prepared from Brg1D/D or Sox10D/D sciatic nerves (Figure 3I,
white and gray bars). These experiments were performed at
postnatal day 6 when Schwann cell numbers were still roughly
comparable in mutant and wild-type nerves. RT-PCR experi-
ments furthermore showed that expression of the Oct6 and
Krox20 genes in Brg1D/D and Sox10D/D sciatic nerves (i.e., under
conditions where SCE and MSE are not occupied by Brg1) was
strongly reduced (Figure 3J). In summary, these findings support
the notion that recruitment of Brg1 to both regulatory regions is
essential for efficient transcription of these genes in Schwann
cells and requires the presence of Sox10.
Functional interactions among Sox10, Brg1, and Baf60a were
further investigated by overexpression studies in N2a cells.
Ectopic expression of Sox10 led to a small but significant
2-fold increase of expression from the endogenous Krox20
gene as determined by quantitative PCR (qPCR) (Figure S3C).
Ectopic Baf60a or Brg1 also increased Krox20 expression levels
4- to 5-fold. Supply of any of these proteins in pairs did not
further stimulate endogenous Krox20 expression. In contrast,
triple transfection with Sox10, Baf60a, and Brg1 increased
expression levels substantially so that Krox20 expression was
12-fold higher than in mock-transfected cells.
Endogenous Krox20 expression was not only stimulated by
Sox10 in N2a cells but also in Hamburger-Hamilton stage
19–20 chicken neural tubes upon in ovo electroporation (Fig-
ure 4A). Electroporation of Sox10 has previously been shown
to induce neural crest characteristics and cause delamination
and emigration of cells from the neural tube (Cheung et al.,
2005). This is visible by the resulting deformation of the neural
tube on the electroporated side and by the induction of neural
crest markers such as HNK-1 (Figure 4B). Whereas HNK-1 was
detected in nearly all Sox10-electroporated cells, Krox20 was
only induced in approximately 35%, indicating that Schwann
cell markers are less inducible than neural crest markers in this
experimental setup (Figure 4C).
Krox20 induction was strongly reduced when validated
shRNAs (Figures S3D and S3E) against chicken Baf60a or
chicken Brg1 were coelectroporated with the Sox10 expression
plasmid (Figure 4A, and for quantification Figure 4C). In contrast,
neither shRNA had an effect on the ability of electroporated cells198 Developmental Cell 23, 193–201, July 17, 2012 ª2012 Elsevier Into emigrate from the neural tube or to induce the neural crest
marker HNK-1 (Figure 4B; for quantification, see Figure 4C),
arguing that Krox20 induction but not the induction of neural
crest characteristics required the BAF complex. A coelectropo-
rated scrambled shRNA control had little effect on either pro-
cess (Figures 4A and 4C). Further evidence for the specificity
of the observed reduction was provided by the ability of ectopic
mouse Baf60a to partially rescue the Sox10-dependent Krox20
induction in the presence of shRNA against chicken Baf60a
(Figures 4A and 4C). Both gain-of-function and loss-of-function
studies thus support the assumption that the glial transcrip-
tion factor Sox10 functionally interacts via Baf60a with Brg1-
containing complexes to exert its function during Schwann cell
development.
DISCUSSION
Although it is generally assumed that changes in chromatin
structure may play an important role in the maintenance of the
differentiated state on a rather global scale by shutting off a
large number of genes whose expression is no longer needed,
the concept is relatively new that chromatin remodeling may
also influence maintenance of the stem cell state or the differen-
tiation process itself (Ho and Crabtree, 2010; Ho et al., 2009;
Lessard et al., 2007; Lickert et al., 2004; Takeuchi and Bruneau,
2009). Our study strongly suggests that Schwann cell differenti-
ation relies on such chromatin-remodeling activity. All available
evidence argues that recruitment of Brg1-containing remodeling
complexes to key regulatory genes is sufficient to introduce
local changes in chromatin structure that then activate expres-
sion of these key regulators. We find Brg1-containing com-
plexes at distant enhancers known to bind Sox10 and to
mediate Schwann cell-specific expression of the key regulators,
and their presence is coupled to the one of Sox10. Therefore, it
is tempting to assume that Sox10 specifically recruits the
chromatin-remodeling complexes to these regions from which
they then start their activity. Such a function from a distance is
compatible with what is known about Brg1-containing com-
plexes (Ho and Crabtree, 2010). Although we do not know on
how many genes these Brg1-containing complexes are active
in differentiating Schwann cells, a very limited number of key
regulatory genes is sufficient to explain their importance in the
process. The ability to recruit chromatin-remodeling complexes
to specific regions in the genome of a differentiating Schwann
cell truly makes Sox10 an ‘‘architectural’’ transcription factor,
thus giving this term originally ascribed to Sox proteins because
of their ability to bend DNA a whole new meaning (Werner
and Burley, 1997). In the context of Schwann cell development,
it will be interesting to see in future experiments whether mul-
tiple Brg1-containing chromatin-remodeling complexes with
different subunit compositions exist and whether these isoforms
exert different stage-specific functions as previously shown for
developing neurons (Brown et al., 2007; Ho and Crabtree,
2010; Lessard et al., 2007). It will also be important to under-
stand the temporal specificity of the observed interaction. After
all, Brg1, Baf60a, and Sox10 are all expressed in the Schwann
cell lineage before their concerted action. Considering that
Sox10 undergoes substantial posttranslational modifications, it
is likely that they restrict the interaction with Brg1-containingc.
Figure 4. Functional Interaction of Sox10 and BAF Complex Components In Vivo
(A and B) Neural tube electroporations were carried out in HH11-stage chicken embryos using expression vectors for Sox10 and mouse Baf60a (mBaf60a), and
pSuper-based plasmids for control (shSCR), Baf60a-specific (shB60a), or Brg1-specific (shBrg1) shRNAs as indicated on the left. Analysis was 24 hr post-
electroporation. The electroporated right side is visualized by GFP expression. Sections were simultaneously probed for the occurrence of Sox10 (white) and
Krox20 (red, in A) or HNK-1 (red in B). Scale bars, 30 mm.
(C) Quantification of the percentage of GFP-positive cells that expressed Krox20 (left) or HNK-1 (right) after electroporation with various combinations of
expression plasmids for Sox10, mBaf60a, and shRNAs. Data were obtained from at least five electroporated embryos per plasmid combination. Three sections
were counted per embryo. Diagrams show mean values ± SEM. Statistical significance between pairs of electroporations was determined by Student’s t test
(***p < 0.001; n.s., not significant).
See also Figure S3.
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of bacterially expressed (and therefore largely unmodified)
Sox10 with Baf60a in GST pull-downs, it may be concluded
that interaction requires the absence rather than presence
of certain posttranslational modifications. It is remarkable that
the interaction involves Sox10 domains that are highly con-
served in Sox9 and Sox8 (Guth and Wegner, 2008). Consider-
ing the essential function of these Sox10 paralogs in many
developmental processes including gonadal, skeletal, pancre-
atic, gut epithelial, kidney, and heart development, it will
be interesting to see whether their action similarly involves
Baf60a-mediated interaction with Brg1-containing chromatin
complexes.DeveEXPERIMENTAL PROCEDURES
Plasmids, Protein Preparation, and Interaction Studies
Expression vectors for Brg1, GST-Baf60a 4-140, and GST-Baf60a 141-435
were provided by T.K. Archer. Generation of all other prokaryotic and eukary-
otic expression plasmids (based on pGEX-KG, pET28b, pGBKT7, pVP16,
pCMV5, pCMV-Sport6, pCAGGS-IRES-nlsGFP, pSuper) for Sox10, Brg1,
Baf60 isoforms, their fragments, and shRNAs was by standard cloning proce-
dures. Full-length proteins were produced in transfected 293 cells and used as
whole-cell extracts, whereas Sox10 and Baf60a fragments were made in
E. coli BL21 DE3 pLysS and purified by chromatography on Ni-NTA beads
for 63His-tagged versions or glutathione Sepharose beads for GST fusions.
GST pull downs were performed as described in the presence of DNase I
(Wissmu¨ller et al., 2006). Detection of precipitated material was by western
blot using antibodies specific to the protein itself (Sox10, Brg1, Baf60a,lopmental Cell 23, 193–201, July 17, 2012 ª2012 Elsevier Inc. 199
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Chromatin-Remodeling Factor Brg1 in GliaBaf60c) or a T7 tag attached to the protein. Interaction screens in yeast were
performed with Sox10 fragments as bait and Baf60a as prey, and interactions
were analyzed by ONPG-based liquid b-galactosidase assays.
Cell Culture, Transfection, Preparation of Nucleic Acids,
Coimmunoprecipitation, ChIP, and qPCR Analysis
Cells kept in culture included 293 embryonic kidney cells, N2a neuroblastoma,
and S16 Schwann cells. 293 cells were transfected with polyethylenimine and
used for preparation of protein extracts (Wissmu¨ller et al., 2006). N2a cells
were transfected using SuperFect reagent and used for RNA preparation.
RNA from N2a cells was reverse transcribed and used to quantify alterations
of endogenous Krox20 gene expression after transfection by qPCR (Finzsch
et al., 2010). S16 cells were the source of whole-cell extracts for coimmuno-
precipitations with antibodies directed against Sox10 and Baf60a (Wissmu¨ller
et al., 2006) and of crosslinked, sheared chromatin for ChIP. Sheared chro-
matin from S16 cells and sciatic nerves was precipitated with Brg1 antibodies
(Abcam; ab4081) and control IgGs (Ku¨spert et al., 2011). The amount of
specific DNA regions present in the precipitate was then quantified to deter-
mine their Brg1-specific enrichment over control IgG. All quantifications
were performed by qPCR on a Bio-Rad CFX96 Touch Real-Time PCR Detec-
tion System. More detailed information on ChIP experiments, including ampli-
fied regions, primer sequences, and data analysis, is given in the Supplemental
Experimental Procedures.
Generation of Mice, Chicken In Ovo Electroporations, and
Phenotypic Analyses
All animal experiments were carried out with permission and in compliance
with animal policies of the State of Bavaria, Germany. Mice with Sox10fl or
Brg1fl allele have been described (Finzsch et al., 2010; Sumi-Ichinose et al.,
1997) and were crossed with mice carrying a Dhh::Cre transgene (Jaegle
et al., 2003) to generate Sox10D/D, Brg1D/D, and Sox10+/D Brg1D/D embryos,
pups, and mice. After genotyping, material from E10.5 embryos to 24-day-
old mice was processed for TUNEL, in situ hybridization with probes specific
forMbp orMpz, or for immunohistochemistry using primary antibodies against
Brg1 (1:40 dilution; Santa Cruz Biotechnology), Baf60a (1:200 dilution; BD
Transduction Laboratories), Sox10, Oct6, Krox20, Sox2, Ki67, Mbp, vonWille-
brand factor, desmin, CD3, and Iba1 (Finzsch et al., 2010). With the exception
of Brg1 and Baf60a antibodies, source and working concentration of all
primary antibodies as well as the fluorophore-labeled secondary antibodies
were as described (Finzsch et al., 2010). Nuclei were counterstained with
DAPI. Sciatic nerves were also used to prepare RNA and quantify expression
levels by RT-PCR (Finzsch et al., 2010). Ultrastructural analysis and histolog-
ical PPD stainings were performed as previously reported (Finzsch et al.,
2010). In ovo electroporations were carried out on chicken embryos at
HH10–11 after injection of expression plasmids into the neural tube. Condi-
tions for electroporation and procedures to obtain, process, and analyze
material 24 hr postelectroporation at HH19–20 by coimmunohistochemistry
using antibodies directed against GFP, Sox10, Krox20, and HNK-1 were as
described (Cossais et al., 2010).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2012.05.017.
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